STRONG REBOUND EXPECTED!!! GOOD SHORT-TERM BUY OPPORTUNITY
A phase two study is expected “in the next couple of months,”
Source: cnbc.com/2021/02/03/covid-vaccine-vaxart-says-its-oral-vaccine-got-promising-results.html
Source: cnbc.com/2021/02/03/covid-vaccine-vaxart-says-its-oral-vaccine-got-promising-results.html
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.